girodazole

structure given in first source; MW 263.55; a new marine cpd isolated from sponge Pseudaxinyssa cantharella

Also Known As:

(1S,2S)-3-amino-1-(4-(2-amino-1H-imidazolyl))-2-chloro-1-propanol,2HCL; NSC 627434; NSC-627434; RP 49532A; RP-49532A

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Neoplasms (Cancer) 01/01/1995 - "Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors." 08/01/1991 - "Girodazole is active in vivo on several murine grafted tumors including leukemias (P388, L1210, i.p./i.p.) and solid tumors (MA 16/C mammary adenocarcinoma, M5076 histiocytosarcoma, s.c./i.v.). "
2.	Leukemia 08/01/1991 - "Girodazole is active in vivo on several murine grafted tumors including leukemias (P388, L1210, i.p./i.p.) and solid tumors (MA 16/C mammary adenocarcinoma, M5076 histiocytosarcoma, s.c./i.v.). "
3.	Adenocarcinoma 08/01/1991 - "Girodazole is active in vivo on several murine grafted tumors including leukemias (P388, L1210, i.p./i.p.) and solid tumors (MA 16/C mammary adenocarcinoma, M5076 histiocytosarcoma, s.c./i.v.). "

1.	Protein Synthesis Inhibitors